Pablo Angeles Tacchino
@pabloangelest.bsky.social
Médico Nefrólogo
Reposted by Pablo Angeles Tacchino
Finally, a large group of patients are those with heterozygous COL4A3 and COL4A4 variants who do well long term with only microscopic hematuria. The problem is that you don't know which patients will fall into this bucket and which will fall into the buckets above by genotyping alone. #KidneyWk
November 6, 2025 at 6:39 PM
Finally, a large group of patients are those with heterozygous COL4A3 and COL4A4 variants who do well long term with only microscopic hematuria. The problem is that you don't know which patients will fall into this bucket and which will fall into the buckets above by genotyping alone. #KidneyWk
Reposted by Pablo Angeles Tacchino
September 26, 2025 at 2:03 AM
Reposted by Pablo Angeles Tacchino
Fervenza has been asked about galactose deficient IgA1. He says he is going to be nice but then says he has nothing nice to say about KDIGO.
He says guidelines are always backward looking. No answer about Gd-IgA1 though
#GlomCon
He says guidelines are always backward looking. No answer about Gd-IgA1 though
#GlomCon
September 26, 2025 at 2:14 AM
Fervenza has been asked about galactose deficient IgA1. He says he is going to be nice but then says he has nothing nice to say about KDIGO.
He says guidelines are always backward looking. No answer about Gd-IgA1 though
#GlomCon
He says guidelines are always backward looking. No answer about Gd-IgA1 though
#GlomCon
Reposted by Pablo Angeles Tacchino
June 5, 2025 at 9:54 AM